Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orskov, C.
Right arrow Articles by Holst, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orskov, C.
Right arrow Articles by Holst, J. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 43, Issue 4 535-539, Copyright © 1994 by American Diabetes Association

ARTICLES

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

C Orskov, L Rabenhoj, A Wettergren, H Kofod and JJ Holst
Department of Medical Anatomy, Panum Institute, Copenhagen, Denmark.

Using specific radioimmunoassays, we studied the occurrence of amidated and glycine-extended glucagon-like peptide I (GLP-I) molecules in the human small intestine and pancreas and in the circulation system in response to a breakfast meal. Through gel permeation chromatography of extracts of the human pancreas (n = 5), we found that 71% of the GLP-I immunoreactivity eluted as a large molecule corresponding to the major proglucagon fragment, 24% corresponded to GLP-I 1-36 amide, and 5% to GLP-I 1-37. By gel permeation chromatography of extracts of human small intestine (n = 6), we found that all immunoreactivity eluted in one peak at the common elution position of the two insulin-releasing peptides, GLP-I 7-36 amide and GLP-I 7-37. Of the GLP-I immunoreactivity, 80% corresponded to GLP-I 7-36 amide and 20% to GLP-I 7-37. The mean concentrations of amidated GLP-I and glycine-extended GLP-I in fasting plasma were 7 +/- 1 and 6 +/- 1 pM, respectively (n = 6). In response to a breakfast meal, the concentration of amidated GLP-I rose significantly amounting to 41 +/- 5 pM 90 min after the meal ingestion, whereas the concentration of glycine-extended GLP-I only rose slightly to a maximum of 10 +/- 1 pM. Thus, both amidated and glycine-extended GLP-I molecules are produced in the small intestine and in the pancreas in humans. Both amidated and glycine-extended GLP-I are measurable in fasting plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
E. Muscelli, A. Mari, A. Casolaro, S. Camastra, G. Seghieri, A. Gastaldelli, J. J. Holst, and E. Ferrannini
Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients
Diabetes, May 1, 2008; 57(5): 1340 - 1348.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Lerche, B. Brock, J. Rungby, H. E. Botker, N. Moller, A. Rodell, B. M. Bibby, J. J. Holst, O. Schmitz, and A. Gjedde
Glucagon-Like Peptide-1 Inhibits Blood-Brain Glucose Transfer in Humans
Diabetes, February 1, 2008; 57(2): 325 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Porksen, L. B. Nielsen, A. Kaas, M. Kocova, F. Chiarelli, C. Orskov, J. J. Holst, K. B. Ploug, P. Hougaard, L. Hansen, et al.
Meal-Stimulated Glucagon Release Is Associated with Postprandial Blood Glucose Level and Does Not Interfere with Glycemic Control in Children and Adolescents with New-Onset Type 1 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2910 - 2916.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. K. Knop, T. Vilsboll, P. V. Hojberg, S. Larsen, S. Madsbad, A. Volund, J. J. Holst, and T. Krarup
Reduced Incretin Effect in Type 2 Diabetes: Cause or Consequence of the Diabetic State?
Diabetes, August 1, 2007; 56(8): 1951 - 1959.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Simonsen, S. Pilgaard, C. Orskov, M. M. Rosenkilde, B. Hartmann, J. J. Holst, and C. F. Deacon
Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G288 - G295.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
L. B Nielsen, K. B Ploug, P. Swift, C. Orskov, I. Jansen-Olesen, F. Chiarelli, J. J Holst, P. Hougaard, S. Porksen, R. Holl, et al.
Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes
Eur. J. Endocrinol., June 1, 2007; 156(6): 663 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Nilsson, J. J Holst, and I. M. Bjorck
Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 996 - 1004.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. K. Lorenzen, S. Nielsen, J. J. Holst, I. Tetens, J. F. Rehfeld, and A. Astrup
Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 678 - 687.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. K. Knop, T. Vilsboll, S. Larsen, P. V. Hojberg, A. Volund, S. Madsbad, J. J. Holst, and T. Krarup
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E324 - E330.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. Muscelli, A. Mari, A. Natali, B. D. Astiarraga, S. Camastra, S. Frascerra, J. J. Holst, and E. Ferrannini
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1144 - E1150.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Ryskjaer, C. F Deacon, R. D Carr, T. Krarup, S. Madsbad, J. Holst, and T. Vilsboll
Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake
Eur. J. Endocrinol., September 1, 2006; 155(3): 485 - 493.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Levin, T. Edholm, P. T. Schmidt, P. Gryback, H. Jacobsson, M. Degerblad, C. Hoybye, J. J. Holst, J. F. Rehfeld, P. M. Hellstrom, et al.
Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3296 - 3302.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
E. R. Pearson, I. Flechtner, P. R. Njolstad, M. T. Malecki, S. E. Flanagan, B. Larkin, F. M. Ashcroft, I. Klimes, E. Codner, V. Iotova, et al.
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
N. Engl. J. Med., August 3, 2006; 355(5): 467 - 477.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. T. Gunnarsson, M. S. Winzell, C. F. Deacon, M. O. Larsen, K. Jelic, R. D. Carr, and B. Ahren
Glucose-Induced Incretin Hormone Release and Inactivation Are Differently Modulated by Oral Fat and Protein in Mice
Endocrinology, July 1, 2006; 147(7): 3173 - 3180.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. E. Wachters-Hagedoorn, M. G. Priebe, J. A. J. Heimweg, A. M. Heiner, K. N. Englyst, Jens. J. Holst, F. Stellaard, and R. J. Vonk
The Rate of Intestinal Glucose Absorption Is Correlated with Plasma Glucose-Dependent Insulinotropic Polypeptide Concentrations in Healthy Men
J. Nutr., June 1, 2006; 136(6): 1511 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Keller, J. J. Holst, and P. Layer
Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G704 - G709.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Theodorakis, O. Carlson, S. Michopoulos, M. E. Doyle, M. Juhaszova, K. Petraki, and J. M. Egan
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E550 - E559.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
W. A. Blom, A. Lluch, A. Stafleu, S. Vinoy, J. J Holst, G. Schaafsma, and H. F. Hendriks
Effect of a high-protein breakfast on the postprandial ghrelin response
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 211 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
W. A. M. Blom, A. Lluch, S. Vinoy, A. Stafleu, R. van den Berg, J. J. Holst, F. J. Kok, and H. F. J. Hendriks
Effects of gastric emptying on the postprandial ghrelin response
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E389 - E395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. Ferchaud-Roucher, E. Pouteau, H. Piloquet, Y. Zair, and M. Krempf
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E716 - E720.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. T. Schmidt, E. Naslund, P. Gryback, H. Jacobsson, J. J. Holst, L. Hilsted, and P. M. Hellstrom
A Role for Pancreatic Polypeptide in the Regulation of Gastric Emptying and Short-Term Metabolic Control
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5241 - 5246.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Proulx, D. Cota, T. R. Castaneda, M. H. Tschop, D. A. D'Alessio, P. Tso, S. C. Woods, and R. J. Seeley
Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R729 - R737.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. H. Schou, K. Pilgaard, T. Vilsboll, C. B. Jensen, C. F. Deacon, J. J. Holst, A. Volund, S. Madsbad, and A. A. Vaag
Normal Secretion and Action of the Gut Incretin Hormones Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide in Young Men with Low Birth Weight
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4912 - 4919.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. H Frid, M. Nilsson, J. J. Holst, and I. M. Bjorck
Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects
Am. J. Clinical Nutrition, July 1, 2005; 82(1): 69 - 75.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger
Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1695 - R1706.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. D. Strader, T. P. Vahl, R. J. Jandacek, S. C. Woods, D. A. D'Alessio, and R. J. Seeley
Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats
Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E447 - E453.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. V Joy, P. T Rodgers, and A. C Scates
Incretin Mimetics as Emerging Treatments for Type 2 Diabetes
Ann. Pharmacother., January 1, 2005; 39(1): 110 - 118.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. A. Nauck, B. Baller, and J. J. Meier
Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S190 - S196.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Nilsson, M. Stenberg, A. H Frid, J. J Holst, and I. M. Bjorck
Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1246 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Hansen, S. Lampert, H. Mineo, and J. J. Holst
Neural regulation of glucagon-like peptide-1 secretion in pigs
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Zander, A. Christiansen, S. Madsbad, and J. Juul Holst
Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes
Diabetes Care, August 1, 2004; 27(8): 1910 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. F. List and J. F. Habener
Glucagon-like peptide 1 agonists and the development and growth of pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E875 - E881.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Hansotia, L. L. Baggio, D. Delmeire, S. A. Hinke, Y. Yamada, K. Tsukiyama, Y. Seino, J. J. Holst, F. Schuit, and D.J. Drucker
Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors
Diabetes, May 1, 2004; 53(5): 1326 - 1335.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Ugleholdt, X. Zhu, C. F. Deacon, C. Orskov, D. F. Steiner, and J. J. Holst
Impaired Intestinal Proglucagon Processing in Mice Lacking Prohormone Convertase 1
Endocrinology, March 1, 2004; 145(3): 1349 - 1355.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K. S Juntunen, D. E Laaksonen, K. Autio, L. K Niskanen, J. J Holst, K. E Savolainen, K.-H. Liukkonen, K. S Poutanen, and H. M Mykkanen
Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread
Am. J. Clinical Nutrition, November 1, 2003; 78(5): 957 - 964.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Vilsboll, F. K. Knop, T. Krarup, A. Johansen, S. Madsbad, S. Larsen, T. Hansen, O. Pedersen, and J. J. Holst
The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide--Regardless of Etiology and Phenotype
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4897 - 4903.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. J. Drucker
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
Diabetes Care, October 1, 2003; 26(10): 2929 - 2940.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. L. Prigeon, S. Quddusi, B. Paty, and D. A. D'Alessio
Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E701 - E707.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. K. Knop, T. Vilsboll, S. Larsen, S. Madsbad, J. J. Holst, and T. Krarup
No Hypoglycemia After Subcutaneous Administration of Glucagon-Like Peptide-1 in Lean Type 2 Diabetic Patients and in Patients With Diabetes Secondary to Chronic Pancreatitis
Diabetes Care, September 1, 2003; 26(9): 2581 - 2587.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Vilsboll, T. Krarup, J. Sonne, S. Madsbad, A. Volund, A. G. Juul, and J. J. Holst
Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2706 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. J. Meier, B. Gallwitz, S. Salmen, O. Goetze, J. J. Holst, W. E. Schmidt, and M. A. Nauck
Normalization of Glucose Concentrations and Deceleration of Gastric Emptying after Solid Meals during Intravenous Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2719 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. P. Vahl, B. W. Paty, B. D. Fuller, R. L. Prigeon, and D. A. D'Alessio
Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on Intravenous Glucose Tolerance and Glucose-Induced Insulin Secretion in Healthy Humans
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1772 - 1779.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Quddusi, T. P. Vahl, K. Hanson, R. L. Prigeon, and D. A. D'Alessio
Differential Effects of Acute and Extended Infusions of Glucagon-Like Peptide-1 on First- and Second-Phase Insulin Secretion in Diabetic and Nondiabetic Humans
Diabetes Care, March 1, 2003; 26(3): 791 - 798.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. L. Kjems, J. J. Holst, A. Volund, and S. Madsbad
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion: Effects on {beta}-Cell Sensitivity in Type 2 and Nondiabetic Subjects
Diabetes, February 1, 2003; 52(2): 380 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Vilsboll, H. Agerso, T. Krarup, and J. J. Holst
Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy Subjects
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 220 - 224.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. W. Van Citters, M. Kabir, S. P. Kim, S. D. Mittelman, M. K. Dea, P. L. Brubaker, and R. N. Bergman
Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5191 - 5198.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. B. Jensen, H. Storgaard, F. Dela, J. J. Holst, S. Madsbad, and A. A. Vaag
Early Differential Defects of Insulin Secretion and Action in 19-Year-Old Caucasian Men Who Had Low Birth Weight
Diabetes, April 1, 2002; 51(4): 1271 - 1280.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Nauck, M. M. Heimesaat, K. Behle, J. J. Holst, M. S. Nauck, R. Ritzel, M. Hufner, and W. H. Schmiegel
Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1239 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K. S Juntunen, L. K Niskanen, K. H Liukkonen, K. S Poutanen, J. J Holst, and H. M Mykkanen
Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects
Am. J. Clinical Nutrition, February 1, 2002; 75(2): 254 - 262.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Meier, K. Hucking, J. J. Holst, C. F. Deacon, W. H. Schmiegel, and M. A. Nauck
Reduced Insulinotropic Effect of Gastric Inhibitory Polypeptide in First-Degree Relatives of Patients With Type 2 Diabetes
Diabetes, November 1, 2001; 50(11): 2497 - 2504.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. E. Doyle, N. H. Greig, H. W. Holloway, J. A. Betkey, M. Bernier, and J. M. Egan
Insertion of an N-Terminal 6-Aminohexanoic Acid after the 7 Amino Acid Position of Glucagon-Like Peptide-1 Produces a Long-Acting Hypoglycemic Agent
Endocrinology, October 1, 2001; 142(10): 4462 - 4468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
F. Y. Enc, N. Imeryuz, L. Akin, T. Turoglu, F. Dede, G. Haklar, N. Tekesin, N. Bekiroglu, B. C. Yegen, J. F. Rehfeld, et al.
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release
Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G752 - G763.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Rask, T. Olsson, S. Soderberg, O. Johnson, J. Seckl, J. J. Holst, and B. Ahren
Impaired Incretin Response After a Mixed Meal Is Associated With Insulin Resistance in Nondiabetic Men
Diabetes Care, September 1, 2001; 24(9): 1640 - 1645.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-B. Toft-Nielsen, M. B. Damholt, S. Madsbad, L. M. Hilsted, T. E. Hughes, B. K. Michelsen, and J. J. Holst
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3717 - 3723.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M.-B. Toft-Nielsen, S. Madsbad, and J. J. Holst
Determinants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3853 - 3860.
[Abstract] [Full Text] [PDF]